Stock ISRG INTUITIVE SURGICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up
PDF Report : Intuitive Surgical, Inc.

Financials Intuitive Surgical, Inc.

Equities

ISRG

US46120E6023

Advanced Medical Equipment & Technology

Market Closed - Nasdaq
Other stock markets
 04:00:00 2023-12-01 pm EST 		Intraday chart for Intuitive Surgical, Inc. 5-day change 1st Jan Change
315.31 USD +1.44% -0.85% +18.83%
Nov. 21 It’s Nvidia Day
Nov. 21 ANALYST RECOMMENDATIONS : Ashtead, Crowdstrike, Hershey, Ulta Beaty, Zoom...

Valuation

Fiscal Period : December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 54 693 68 321 96 172 128 355 93 771 109 438 - -
Enterprise Value (EV) 1 51 968 67 154 94 550 127 064 92 189 104 777 103 121 100 704
P/E ratio 50,5x 51,2x 92,8x 77,1x 72,7x 69,3x 58,1x 48,3x
Yield - - - - - - - -
Capitalization / Revenue 14,7x 15,3x 22,1x 22,5x 15,1x 15,5x 13,5x 11,9x
EV / Revenue 14,0x 15,0x 21,7x 22,3x 14,8x 14,8x 12,8x 11,0x
EV / EBITDA 31,3x 35,0x 54,6x 48,4x 37,1x 37,8x 32,1x 27,5x
EV / FCF 52,9x 57,3x 82,7x 73,2x 96,2x 64,9x 49,1x 39,2x
FCF Yield 1,89% 1,75% 1,21% 1,37% 1,04% 1,54% 2,04% 2,55%
Price to Book 8,52x 8,30x 8,62x 10,8x 8,41x 8,26x 6,68x 5,50x
Nbr of stocks (in thousands) 342 601 346 721 352 666 357 237 353 385 352 072 - -
Reference price 2 160 197 273 359 265 315 315 315
Announcement Date 24.01.19 23.01.20 21.01.21 20.01.22 24.01.23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period : December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 3 724 4 479 4 358 5 710 6 222 7 070 8 084 9 196
EBITDA 1 1 660 1 921 1 732 2 625 2 487 2 774 3 208 3 660
EBIT 1 1 537 1 785 1 515 2 315 2 149 2 403 2 792 3 260
Operating Margin 41,3% 39,9% 34,8% 40,5% 34,5% 34,0% 34,5% 35,4%
Earnings before Tax (EBT) 1 1 280 1 502 1 207 1 890 1 607 2 086 2 538 3 010
Net income 1 1 128 1 379 1 061 1 705 1 322 1 626 1 921 2 297
Net margin 30,3% 30,8% 24,3% 29,9% 21,3% 23,0% 23,8% 25,0%
EPS 2 3,16 3,85 2,94 4,66 3,65 4,55 5,43 6,52
Free Cash Flow 1 982 1 173 1 143 1 736 958 1 613 2 100 2 572
FCF margin 26,4% 26,2% 26,2% 30,4% 15,4% 22,8% 26,0% 28,0%
FCF Conversion (EBITDA) 59,2% 61,1% 66,0% 66,1% 38,5% 58,2% 65,5% 70,3%
FCF Conversion (Net income) 87,1% 85,0% 108% 102% 72,5% 99,2% 109% 112%
Dividend per Share 2 - - - - - - - -
Announcement Date 24/01/19 23/01/20 21/01/21 20/01/22 24/01/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period : December 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 1 464 1 403 1 551 1 488 1 522 1 557 1 655 1 696 1 756 1 744 1 877 1 893 2 000 2 003 2 156
EBITDA 1 706 652 669 611 611 637 628 627 710 732 726 740 795 806 842
EBIT 1 630 570 588 533 531 555 530 535 618 624 628 638 694 702 737
Operating Margin 43,0% 40,6% 37,9% 35,8% 34,9% 35,6% 32,0% 31,5% 35,2% 35,8% 33,5% 33,7% 34,7% 35,0% 34,2%
Earnings before Tax (EBT) 1 526 461 454 402 407 403 395 422 499 522 574 546 586 589 628
Net income 1 517 381 381 366 308 324 325 355 421 416 430 440 468 471 511
Net margin 35,3% 27,1% 24,5% 24,6% 20,2% 20,8% 19,6% 20,9% 24,0% 23,8% 22,9% 23,2% 23,4% 23,5% 23,7%
EPS 2 1,42 1,04 1,04 1,00 0,85 0,90 0,91 1,00 1,18 1,16 1,21 1,24 1,32 1,35 1,46
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 07/20/21 10/19/21 01/20/22 04/21/22 07/21/22 10/18/22 01/24/23 04/18/23 07/20/23 10/19/23 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period : December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 - - - - - - - -
Net Cash position 1 2 725 1 168 1 623 1 291 1 581 4 661 6 317 8 734
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 982 1 173 1 143 1 736 958 1 613 2 100 2 572
ROE (net income / shareholders' equity) 22,8% 20,4% 13,6% 16,8% 14,7% 15,3% 15,0% 14,7%
Shareholders' equity 1 4 951 6 770 7 805 10 159 8 997 10 641 12 833 15 597
ROA (Net income/ Total Assets) 19,2% 17,4% 11,7% 14,7% 13,2% 13,0% 12,5% 12,1%
Assets 1 5 887 7 949 9 065 11 607 9 995 12 521 15 338 18 923
Book Value Per Share 2 18,7 23,7 31,6 33,3 31,5 38,1 47,2 57,3
Cash Flow per Share 2 3,28 4,46 4,11 5,71 4,12 6,33 7,65 8,71
Capex 1 187 426 342 354 532 887 735 711
Capex / Sales 5,03% 9,50% 7,84% 6,19% 8,56% 12,5% 9,10% 7,73%
Announcement Date 01/24/19 01/23/20 01/21/21 01/20/22 01/24/23 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Intuitive Surgical, Inc.

Trading Rating :
Investor Rating :
ESG Refinitiv :
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
315.20USD
Average target price
326.63USD
Spread / Average Target
+3.63%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+18.83% 109 B $
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
-9.91% 192 B $
DANAHER CORPORATION Stock Danaher Corporation
-15.80% 165 B $
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+21.33% 81 878 M $
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+13.76% 64 423 M $
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-8.19% 49 296 M $
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
-8.38% 41 066 M $
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-13.94% 37 333 M $
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+18.89% 31 166 M $
RESMED, INC. Stock ResMed, Inc.
-23.30% 23 201 M $
Other Advanced Medical Equipment & Technology
  1. Stock
  2. Equities
  3. Stock Intuitive Surgical, Inc. - Nasdaq
  4. Financials Intuitive Surgical, Inc.
The best tools reserved for subscribers to boost the performance of your investments!
Optimize my profits
fermer